Business
Bionano Genomics Announces American Society of Hematology (ASH) Annual Meeting Presentations Featuring OGM Utility Across Blood Cancer Research Applications
A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use of
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use of emerging technologies for prognostication and research into myeloid neoplasmsFour scientific posters featuring results from OGM applications in myeloid cancers, acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS) and hematological malignancy research, including one poster covering a multi-site study in Spain on data analysis for OGM for leukemia and lymphoma research, will be presented at the conference SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American Society of Hematology (ASH) Annual Meeting and Exposition 2022 with a broad range of content covering optical genome mapping’s (OGM) utility for research areas including myeloid cancer, hematological malignancy, leukemia and blood disorders. ASH’s Annual Meeting brings together industry, medical, and academic professionals to discuss advances in the field of blood disease. The ASH conference will be held December 10-13, 2022, in New Orleans, Louisiana. Poster presentations and scientific workshop sessions on OGM include: Poster NumberTitleAuthorsPresented2177Pilot Inter-Laboratory Comparison Study of Optical Genome Mapping Analysis for Cytogenomic Characterization of Hematological Malignancies: A Spanish Multicentric StudyPuiggros A., Mallo M., Salido M., Gómez-García A., Cisneros A., García-Serra R., González-Gil C., Avetisyan G., Rodríguez-Rivera M., Diaz-Gonzalez A., Granada I., Such E., Genescà E., Collado R., Ramírez-Orellana M., Solé F., Espinet B.December 10, 20225:30-7:30 PM CSTSession 8033496Combined Structural Variant and Mutation Profiling for Comprehensive Characterization for Chromoanagenesis and TP53 Mutations in Myelodysplastic Syndromes with Complex KaryotypeKanagal-Shamanna, R., Yang H., Garcia-Manero G., Wei Y., Sasaki K., Chien K., Tang Z., Montalban-Bravo G., Kalia A., Luthra R., Medeiros J.December 11, 20226:00-8:00 PM CSTSession 8033496Combined Structural Variant and Mutation Profiling for Comprehensive Characterization for Chromoanagenesis and TP53 Mutations in Myelodysplastic Syndromes with Complex KaryotypeKanagal-Shamanna, R., Yang H., Garcia-Manero G., Wei Y., Sasaki K., Chien K., Tang Z., Montalban-Br...